Request Consultation
search-icon
Download Videssa Guide

Provista Blog > [Media Round-Up]: New Study on Breast Cancer Blood Test

Provista Blog

[Media Round-Up]: New Study on Breast Cancer Blood Test

Posted by Provista Diagnostics on June 1, 2017
Share:     

Last week the Clinical Breast Cancer journal published our latest study "A Non-Invasive Blood-Based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years". This study looks at the two prospective clinical trials we conducted to develop a blood-based Combinatorial Proteomic Biomarker Assay (Videssa Breast) to accurately detect breast cancer and reduce false positives from suspicious imaging findings. 

Read the study from the Clinical Breast Cancer journal here.

The study concludes: "Videssa® Breast can effectively detect breast cancer when used in conjunction with imaging and can substantially reduce unnecessary medical procedures, as well as provide assurance to women that they likely do not have breast cancer."

Take a look at what others are saying about the latest study and Videssa Breast here:

 

Screen Shot 2017-05-25 at 12.46.21 PM.png

 

Provista Publishes First Prospective Study on Videssa Breast Test

May 23, 2017 | GenomeWeb, 360Dx Adam Bonislawski

Read More
May24_2017_Getty_176427895_BloodVesselDNA_5007570160213.jpg

Breast Cancer Liquid Biopsy Study Validates Test as Improved Diagnostic Tool

May 24, 2017 | Genetic Engineering & Biotechnology News

Read More
blood-sample.jpg

Blood Test May Detect Breast Cancer, Provide Effective Alternative To Invasive Biopsies

May 24, 2017 | Medical Daily, 

Read More
GettyImages-a0183-000060h-1.jpg

Scientists Just Made a Huge Breakthrough in Diagnosing Breast Cancer

May 25, 2017 | Allure Magazine, Rosemary Donahue

Read More
MMG-BREAST-TUMOR-IMAGE_highres-16-1200x905-992530-edited.jpg

Blood-Based Breast Cancer Detection Test May Help Avoid Biopsy

May 25, 2017 | Forbes, John Nosta

Read More 

 

clinical-breast-cancer-media-round-up
Provista Diagnostics

Provista Diagnostics

At Provista Diagnostics, our mission is to develop world-class diagnostic tests for indications in breast and gynecologic cancers. As a leading diagnostics company, our aim is to create, produce and market innovative solutions for unmet clinical needs. Our products and services help to diagnose diseases and inform better clinical decisions, thus enhancing women’s health and quality of life. We do this in a responsible and ethical manner with a commitment to excellence in every aspect of our business.